Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356221 | 12535622 | 1 | I | 20160630 | 0 | 20160706 | 20160706 | DIR | 3.91 | YR | F | N | 13.30000 | KG | 20160705 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125356221 | 12535622 | 1 | PS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | 610 | MG | ||||||||||
| 125356221 | 12535622 | 3 | C | CYTARABINE. | CYTARABINE | 1 | 48 MG WAS GIVEN?IT | 0 | 366.4 | MG | |||||||||
| 125356221 | 12535622 | 5 | C | THIOGUANINE (6-TG) | THIOGUANINE ANHYDROUS | 1 | 0 | 520 | MG | ||||||||||
| 125356221 | 12535622 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | 84 | MG | ||||||||||
| 125356221 | 12535622 | 9 | C | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | 45.6 | MG | ||||||||||
| 125356221 | 12535622 | 11 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | GIVEN IT | 0 | 24 | MG | |||||||||
| 125356221 | 12535622 | 13 | C | METHOTREXATE. | METHOTREXATE | 1 | GIVEN IT | 0 | 24 | MG | |||||||||
| 125356221 | 12535622 | 15 | C | ONCASPAR | PEGASPARGASE | 1 | 0 | 3050 | IU | ||||||||||
| 125356221 | 12535622 | 17 | C | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 4.5 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125356221 | 12535622 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125356221 | 12535622 | Anaemia | |
| 125356221 | 12535622 | Febrile neutropenia | |
| 125356221 | 12535622 | Fluid overload | |
| 125356221 | 12535622 | General physical health deterioration | |
| 125356221 | 12535622 | Human rhinovirus test positive | |
| 125356221 | 12535622 | Hyperglycaemia | |
| 125356221 | 12535622 | Hypotension | |
| 125356221 | 12535622 | Lung infiltration | |
| 125356221 | 12535622 | Pneumonia | |
| 125356221 | 12535622 | Respiratory distress | |
| 125356221 | 12535622 | Tachypnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125356221 | 12535622 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125356221 | 12535622 | 1 | 20160601 | 0 | ||
| 125356221 | 12535622 | 3 | 20160611 | 0 | ||
| 125356221 | 12535622 | 5 | 20160614 | 0 | ||
| 125356221 | 12535622 | 7 | 20160515 | 0 | ||
| 125356221 | 12535622 | 9 | 20160509 | 0 | ||
| 125356221 | 12535622 | 11 | 20160601 | 0 | ||
| 125356221 | 12535622 | 13 | 20160601 | 0 | ||
| 125356221 | 12535622 | 15 | 20160615 | 0 | ||
| 125356221 | 12535622 | 17 | 20160622 | 0 |